← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Praxis Bioresearch, Llc
Los Angeles, CA
$4,464,010
Total funding
2
Grants
Funding over time
peak $1.5M · FY2018–22$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,464,010 · 2
By mechanism
R44$4,464,010 · 2
Investigators at Praxis Bioresearch, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Novel Dopaminergic Stimulant Prodrug for the Treatment of Apathy in AD$1,451,070
R44 · FY2021 · AG
Novel Dopaminergic Stimulant Prodrug for the Treatment of Apathy in AD$957,571
R44 · FY2022 · AG
Validating Prodrug PRX-P4-003 approach in humans by phase 0 microdose study$662,269
R44 · FY2019 · MH
Validating Prodrug PRX-P4-003 approach in humans by phase 0 microdose study$535,295
R44 · FY2020 · MH
Novel Dopaminergic Stimulant Prodrug for the Treatment of Apathy in AD$448,752
R44 · FY2020 · AG
Validating Prodrug PRX-P4-003 approach in humans by phase 0 microdose study$300,139
R44 · FY2018 · MH
Validating Prodrug PRX-P4-003 approach in humans by phase 0 microdose study$58,914
R44 · FY2019 · MH
Novel Dopaminergic Stimulant Prodrug for the Treatment of Apathy in AD$50,000
R44 · FY2022 · AG